MARKET

FBRX

FBRX

Forte Biosciences Inc
NASDAQ
0.9783
-0.0072
-0.73%
After Hours: 0.9733 -0.005 -0.51% 19:27 03/29 EDT
OPEN
0.9700
PREV CLOSE
0.9855
HIGH
0.9908
LOW
0.9616
VOLUME
30.65K
TURNOVER
0
52 WEEK HIGH
1.550
52 WEEK LOW
0.8977
MARKET CAP
20.54M
P/E (TTM)
-1.2454
1D
5D
1M
3M
1Y
5Y
BML Investment Partners Now Owns 8.26% of Forte Biosciences (FBRX)
NASDAQ · 8h ago
Insider Buy: Forte Biosciences
Insider Buy: Forte Biosciences
MT Newswires · 12/19/2022 16:32
Forte Biosciences GAAP EPS of -$0.18 misses by $0.03
Seekingalpha · 11/15/2022 11:13
Forte Biosciences, Inc. - Common Stock Q3 EPS $(0.18) Up From $(0.54) YoY
Benzinga · 11/14/2022 21:32
BRIEF-Forte Biosciences Inc. Announces Third Quarter 2022 Results, Provides Business Update
Reuters · 11/14/2022 21:07
Forte Biosciences Q3 Loss Narrows
Forte Biosciences Q3 Loss Narrows
MT Newswires · 11/14/2022 16:34
BRIEF-Funicular Funds Lp Says On August 24, Sent Letter To Forte Biosciences Inc’S Board Of Directors - SEC Filing
BRIEF-Funicular Funds Lp Says On August 24, Sent Letter To Forte Biosciences Inc’S Board Of Directors - SEC Filing
Reuters · 08/24/2022 21:23
Large Forte Biosciences shareholder scolds company board of directors
Funicular Funds, which owns 8% of the outstanding shares of Forte Biosciences (NASDAQ:<a href="https://seekingalpha.com/symbol/FBRX?utm_medium=referral&utm_source=webull.com" title="Forte Biosciences, Inc....
Seekingalpha · 08/24/2022 20:47
More
About FBRX
Forte Biosciences, Inc. is a biopharmaceutical company. The Company is focused on its lead product candidate, FB-401, which is a topical live biotherapeutic for the treatment of inflammatory skin diseases, including pediatric and adult patients with atopic dermatitis (AD). FB-401, consists of three therapeutic strains of a commensal gram-negative bacteria, Roseomonas mucosa that is specifically selected for their impact on parameters of inflammatory skin disease. It has completed a phase I/II a study, including both adults and pediatric patients, demonstrating reduction in atopic dermatitis disease and pruritus, as well as control of S. aureus while tapering/eliminating steroid use. Its subsidiaries include Forte Subsidiary, Inc., and Forte Biosciences Emerald Limited.

Webull offers kinds of Forte Biosciences Inc stock information, including NASDAQ:FBRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FBRX stock methods without spending real money on the virtual paper trading platform.